| East Alabama Medical Center Skilled Nursing Facili | |
| 2000 Pepperell Parkway, Opelika, Alabama 36802 | |
| (334) 705-4181 | |
| Name | East Alabama Medical Center Skilled Nursing Facili |
|---|---|
| Location | 2000 Pepperell Parkway, Opelika, Alabama |
| Certified By | Medicare |
| No. of Certified Beds | 26 |
| Occupancy Rate | 56.54% |
| Medicare ID (CCN) | 015410 |
| Legal Business Name | The East Alabama Health Care Authority |
| Ownership Type | Non Profit - Other |
| NPI Number | 1871661298 |
| Organization Name | THE EAST ALABAMA HEALTH CARE AUTHORITY |
| Doing Business As | EAST ALABAMA MEDICAL CENTER SKILLED NURSING FACILITY |
| Address | 2000 Pepperell Pkwy, Opelika, AL 36801 |
| Phone Number | 334-528-4170 |
News Archive
Bristol-Myers Squibb will soon announce an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide. The agreement, with the ADAP Crisis Task Force (ACTF) of the National Alliance of State & Territorial AIDS Directors, is expected to be announced any day. BMS has been the target of a sustained advocacy campaign led by AHF over its pricing of its key AIDS drug Reyataz.
"In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer's disease," said Stacy Pagos Haller, President and CEO of the American Health Assistance Foundation (AHAF), a nonprofit that identifies and funds exceptionally high-impact research worldwide through its Alzheimer's Disease Research program.
Chesapeake Regional Medical Center rolled out the newest member of its environmental team last week, a five-foot, automated disinfection robot named Tru-D (Total Room Ultraviolet Disinfection). Implementation of the mobile, high-tech disinfection device is part of a $2 million CDC grant awarded to Duke University for the prevention of healthcare-associated infections (HAI's).
A positive, trusting relationship between counselor and patient, known as a "therapeutic alliance," can be key to successful treatment of alcohol use disorder, a new study finds.
Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Bristol-Myers Squibb will soon announce an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide. The agreement, with the ADAP Crisis Task Force (ACTF) of the National Alliance of State & Territorial AIDS Directors, is expected to be announced any day. BMS has been the target of a sustained advocacy campaign led by AHF over its pricing of its key AIDS drug Reyataz.
"In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer's disease," said Stacy Pagos Haller, President and CEO of the American Health Assistance Foundation (AHAF), a nonprofit that identifies and funds exceptionally high-impact research worldwide through its Alzheimer's Disease Research program.
Chesapeake Regional Medical Center rolled out the newest member of its environmental team last week, a five-foot, automated disinfection robot named Tru-D (Total Room Ultraviolet Disinfection). Implementation of the mobile, high-tech disinfection device is part of a $2 million CDC grant awarded to Duke University for the prevention of healthcare-associated infections (HAI's).
A positive, trusting relationship between counselor and patient, known as a "therapeutic alliance," can be key to successful treatment of alcohol use disorder, a new study finds.
Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 0 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 0 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 0 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 0 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 0 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.97 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 0 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 0 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 0 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 0 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 43.37 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.18 | 82.93 |
News Archive
Bristol-Myers Squibb will soon announce an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide. The agreement, with the ADAP Crisis Task Force (ACTF) of the National Alliance of State & Territorial AIDS Directors, is expected to be announced any day. BMS has been the target of a sustained advocacy campaign led by AHF over its pricing of its key AIDS drug Reyataz.
"In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer's disease," said Stacy Pagos Haller, President and CEO of the American Health Assistance Foundation (AHAF), a nonprofit that identifies and funds exceptionally high-impact research worldwide through its Alzheimer's Disease Research program.
Chesapeake Regional Medical Center rolled out the newest member of its environmental team last week, a five-foot, automated disinfection robot named Tru-D (Total Room Ultraviolet Disinfection). Implementation of the mobile, high-tech disinfection device is part of a $2 million CDC grant awarded to Duke University for the prevention of healthcare-associated infections (HAI's).
A positive, trusting relationship between counselor and patient, known as a "therapeutic alliance," can be key to successful treatment of alcohol use disorder, a new study finds.
Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.
› Verified 5 days ago
Arbor Springs Health And Rehab Center, Ltd Location: 1910 Pepperell Pkwy, Opelika, Alabama 36801 Phone: (334) 749-1471 | |
East Alabama Medical Center Skilled Nursing Facili Location: 2000 Pepperell Parkway, Opelika, Alabama 36802 Phone: (334) 705-4181 |